Deep Tech Startups

A wearable device company developing brain-sensing technology using nanotechnology for consumer use.

3 investors

Atomic Canyon builds AI-powered search and generative AI tools, including its Neutron product, that process nuclear documentation and terminology to support document retrieval, compliance, and plant operations for the nuclear energy industry. It works with the U.S. Nuclear Regulatory Commission's database and has partnered with PG&E's Diablo Canyon Power Plant for on-site generative AI deployment.</parameter> <parameter name="founders">[]

3 investors

Autopoiesis builds AI systems capable of autonomous scientific discovery, operating Aristotle, an AI research partner that assists scientists with hypothesis formation, evidence evaluation, and research direction decisions.

3 investors

Avammune is a drug discovery company developing novel therapeutics for hard-to-treat solid tumors using computational chemistry, immunology, and targeted radiotherapeutics. The company focuses on converting immunologically cold tumors into responsive ones and identifying new cancer dependencies as therapeutic targets.

3 investors

Avegant develops LED light engine technology, including the AG-30L2, for lightweight augmented reality glasses. The company builds compact display components aimed at enabling AR experiences in everyday wearable devices.

3 investors

AVES Reality builds AVES Launcher, a software platform that automatically generates georeferenced, semantic 3D digital twin worlds from geospatial and satellite data, including HD road maps in the ASAM OpenDRIVE standard and 3D mesh models exportable to engines like Unreal Engine 5. It serves simulation and visualization workflows in automotive R&D, smart city planning, and defense.

3 investors

Avisi Technologies develops nanotechnology-enabled implantable devices to lower intraocular pressure in patients with open-angle glaucoma. Its products are investigational ophthalmic medical devices currently in clinical trials.

3 investors

Avivomed is a medical device company developing minimally invasive neuromodulation therapies for patients with obstructive sleep apnea. Based in the Minneapolis area, it targets mild-to-moderate OSA patients who cannot tolerate CPAP.

3 investors

Axelspace provides microsatellite services through its "AxelLiner" one-stop offering — covering design, manufacturing, launch arrangement, and post-launch operation — and operates the "AxelGlobe" Earth observation platform built on its GRUS satellite constellation. The company serves satellite and Earth observation customers and is headquartered in Tokyo, Japan.

3 investors

Axithra develops a photonics-based device using Raman spectroscopy on a chip to measure the free, active fraction of drugs in patient blood for bedside therapeutic drug monitoring. The technology, aimed at healthcare professionals and targeting antibiotics, oncology drugs, and antifungals, is under development and clinical investigation and not yet commercially available.

3 investors

Axol Bioscience manufactures human induced pluripotent stem cell (iPSC)-derived cells and provides laboratory services including iPSC banking, reprogramming, gene editing, and cell manufacturing for preclinical drug discovery and disease modeling. It serves pharmaceutical companies, CROs, biotech firms, and academic institutions across neuroscience, ophthalmology, dermatology, and cardiovascular research, shipping from US and European hubs.</parameter> <parameter name="founders">[]

3 investors

b12 develops AI agents and lab automation software to help chemists plan, optimize, and execute the synthesis of complex molecules. The platform combines chemistry expertise with agentic AI systems to streamline organic synthesis workflows.

3 investors

BACTA is an AI-powered bioproduction company that uses microorganisms to produce industrial ingredients such as astaxanthin for cosmetics, human nutrition, and animal nutrition markets.

3 investors

Bacto.bio is a biotechnology company developing a multidisciplinary pipeline, staffed by scientists, engineers, and other technical specialists.

3 investors

Baraja manufactures LiDAR sensors using Spectrum-Scan technology for autonomous vehicles and self-driving applications.

3 investors

Basetwo provides AI solutions that optimize manufacturing operations for Fortune 500 companies in pharmaceuticals, specialty chemicals, and personal care. The software helps manufacturing teams improve productivity, speed, and resilience across operations in Europe, Asia, and North America.

3 investors

The company builds "Biological Adapters" that integrate living neurons with AI foundation models to improve performance and reduce training cost, and it operates an algorithm discovery platform based on principles from biological neural systems. Its technology (TBC) targets applications such as computer vision, generative video, world models, robotics, and time-series prediction.

3 investors

Becoming.ai develops robotic closed-loop hardware that sustains mammalian development externally—regulating nutrients, waste, and gas exchange—paired with AI models that learn to predict how development unfolds and responds to intervention. The platform combines biology, robotics, and machine learning to make developmental processes testable and predictable, targeting research into developmental disease.

3 investors

Bedrock Ocean manufactures autonomous underwater vehicles (AUVs) and a cloud platform that collect high-resolution seafloor mapping and monitoring data for offshore energy, maritime infrastructure, defense, and scientific research sectors.

3 investors

Biodock provides an AI image analysis platform designed for researchers and scientists to train, run, and interpret deep learning models on biological images without requiring coding expertise. The platform enables rapid model creation, distributed execution at scale, and detailed quantitative analysis for research organizations in biotech and life sciences.

3 investors

BioHive develops skin organoid technology derived from iPSCs, offering customizable organoids with multiple cell types for toxicity, efficacy, and inflammatory analysis. It serves the pharmaceutical and dermo-cosmetic industries to reduce R&D costs and reliance on animal models.

3 investors

BIOIO develops a genetics-based platform for elucidating drug mechanisms of action, combining decades of research in pharmacology with big data and automation to accelerate drug discovery and development. The company serves pharmaceutical and biotech organizations seeking to understand how drugs work.

3 investors

Biolojic uses machine learning to design programmable human antibodies, including epitope-specific binders and multi-specific "multibodies," that act as functional switches targeting validated biological pathways. Its drug pipeline focuses on treatments for autoimmune diseases and immuno-oncology.

3 investors

Bioqore builds Voyager, an AI-powered closed-loop bioprocess intelligence platform that combines predictive modeling with micro-scale laboratory experiments to recommend and validate optimal process conditions for producing preclinical- and clinic-ready therapeutic candidates. It serves biotech and pharma teams working on bioprocess development, scale-up, and biomanufacturing.

3 investors